American Gastroenterological Association Institute Guideline on the Management of Crohn's Disease After Surgical Resection

Gastroenterology

Volumn 152, Issue 1, 2017, Pages 271-275

  Nguyen, Geoffrey C ^a   Loftus, Edward V ^b   Hirano, Ikuo ^c   Falck–Ytter, Yngve ^d   Singh, Siddharth ^e   Sultan, Shahnaz ^f   Flamm, Steven L ^g   Lim, Joseph K ^g   Rubenstein, Joel H ^g   Smalley, Walter E ^g   Stollman, Neil ^g   Vege, Santhi Swaroop ^g   Wani, Sachin B ^g   Weinberg, David S ^g   Yang, Yu Xiao ^g  

^a UNIVERSITY OF TORONTO   (Canada)

^b MAYO CLINIC   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; MERCAPTOPURINE; MESALAZINE; NITROIMIDAZOLE; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; ASYMPTOMATIC DISEASE; COLONOSCOPY; CONTROLLED CLINICAL TRIAL (TOPIC); CROHN DISEASE; HUMAN; MEDICAL SOCIETY; PATIENT MONITORING; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RECURRENT DISEASE; REMISSION; COLON RESECTION; CONSENSUS; EVIDENCE BASED MEDICINE; GASTROENTEROLOGY; STANDARDS; TREATMENT OUTCOME; UNITED STATES;

COLECTOMY; CONSENSUS; CROHN DISEASE; EVIDENCE-BASED MEDICINE; GASTROENTEROLOGY; HUMANS; POSTOPERATIVE CARE; SOCIETIES, MEDICAL; TREATMENT OUTCOME; UNITED STATES;

EID: 85006267601     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.10.038     Document Type: Article

References (8)

1. 1 Regueiro, M., Velayos, F., Greer, J.B., et al. American Gastroenterological Association technical review on the management of Crohn's disease after surgical resection. Gastroenterology 152 (2017), 277–295.
2. 2 http://www.gastro.org/practice/medical-position-statements/aga-institute-clinical-practice-guideline-development-process.
3. 3 Graham, R., Mancher, M., Wolman, D.M., et al. Clinical practice guidelines we can trust. Institute of Medicine, 2011, The National Academies Press, Washington, DC.
4. 4 Sultan, S., Falck-Ytter, Y., Inadomi, J.M., The AGA Institute process for developing clinical practice guidelines part one: grading the evidence. Clin Gastroenterol Hepatol 11 (2013), 329–332.
5. 5 Terdiman, J.P., Gruss, C.B., Heidelbaugh, J.J., et al., AGA Institute Clinical Practice and Quality Management Committee. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti–TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology 145 (2013), 1459–1463.
6. 6 Ford, A.C., Kane, S.V., Khan, K.J., et al. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol 106 (2011), 617–629.
7. 7 Lim, W.C., Hanauer, S., Aminosalicylates for induction of remission or response in Crohn's disease. Cochrane Database Syst Rev(12), 2010, CD008870.
8. 8 De Cruz, P., Kamm, M.A., Hamilton, A.L., et al. Crohn's disease management after intestinal resection: a randomised trial. Lancet 385 (2015), 1406–1417.